Login
← Go Back
Natco Pharma
NATCOPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: V C Nannapaneni · MD: V C Nannapaneni · Listing date: Dec. 27, 1995 · Employees: 5046 · Hyderabad · http://www.natcopharma.co.in
Stock Price vs Company Growth
1d
0.7%
1w
6.5%
1m
10.1%
3m
1.4%
6m
16.1%
1y
33.6%
5y
0.9%
10y
5.6%
all
20.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 834 0.7%
791
961
Company Overview
Sales
4,388 Cr
Growth: 5.7%
Profit after Tax
1,539 Cr
Growth: -9.4%
Mid Cap
14,935 Cr
P/E: 9.7x
Industry P/E: 30.2x
Fundamentals
Sales (Cr) ₹ 4,388
Growth 5.7%
EBITDA 39.6%
P/S 3.4x
Dividend 0.5%
P/E 9.7x
Book Value ₹ 480
PEG Ratio 1.7x
ROE 19.5%
P/B 1.7x
Shareholding Pattern
Institutions
Qualified Institutional Buyers
6.25 %
Mirae Asset Emerging Bluechip Fund
4.06 %
Life Insurance Corporation Of India
2.46 %
Plenty Private Equity Fii I Limited
1.74 %
Nomura Singapore Limited
1.69 %
Promoters
V C Nannapaneni
12.39 %
Time Cap Pharma Labs Limited
9.42 %
Venkata Satya Swathi Kantamani
8.77 %
Natsoft Information Systems Pvt Ltd
8.65 %
Venkaiah Chowdary Nannapaneni Huf
2.98 %
Others
Increase    Decrease    No change
Company Profile Detailed
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.
Belongs to (26 Indices) view more
Investors (172)
marshall...
ndl.infr...
nomura.i...
Followers (40)
nitin2
keerthi
deepak